Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Chapel Hill, North Carolina


Purpose:

To study the efficacy and tolerability of gemcitabine/platinum chemotherapy in non small cell lung cancer


Criteria:

Inclusion Criteria: - Histologically of cytologically confirmed non small cell lung cancer - No prior chemotherapy or radiation - No prior malignancy Exclusion Criteria: - Pregnant or breastfeeding - Serious concomitant systemic disorder


NCT ID:

NCT00191230


Primary Contact:

Study Director
Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon-Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST)
Eli Lilly and Company


Backup Contact:

N/A


Location Contact:

Chapel Hill, North Carolina
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: October 09, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.